Aclarion, Inc. (ACON) is trading at $1.44, down 79.31 percent or $5.55 during Thursday's trading, despite announcing plans to expand Nociscan access across key markets in New York and New Jersey.
The stock opened at $2.1100 and has traded between $1.0500 and $2.2558 today, compared to its previous close of $7.0000. Current volume is 27.45 million shares, significantly higher than the average volume of 2.41 million. Its 52-week range is $1.0500 to $231.1500.
The company's expansion builds on existing partnerships with RadNet affiliates, leveraging increased availability of MR Spectroscopy and enhanced remote operations to meet growing demand.
For comments and feedback: editorial@rttnews.com